IRIS
ARBITRIO, Mariamena
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 750
EU - Europa 634
AS - Asia 478
SA - Sud America 69
AF - Africa 27
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 5
Totale 1.969
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 714
IT - Italia 327
SG - Singapore 239
DE - Germania 85
GB - Regno Unito 72
IN - India 52
BR - Brasile 51
FI - Finlandia 35
HK - Hong Kong 29
CN - Cina 27
CA - Canada 24
SE - Svezia 24
JO - Giordania 21
PK - Pakistan 21
NL - Olanda 18
ID - Indonesia 17
ES - Italia 12
FR - Francia 10
RU - Federazione Russa 10
SA - Arabia Saudita 9
ZA - Sudafrica 9
BD - Bangladesh 8
CZ - Repubblica Ceca 7
LT - Lituania 7
MX - Messico 7
PT - Portogallo 7
AE - Emirati Arabi Uniti 6
CO - Colombia 6
TR - Turchia 6
AU - Australia 5
EG - Egitto 5
ET - Etiopia 5
IE - Irlanda 5
IQ - Iraq 5
IR - Iran 5
JP - Giappone 5
LB - Libano 5
NG - Nigeria 5
CY - Cipro 4
EC - Ecuador 4
EU - Europa 4
MY - Malesia 4
BG - Bulgaria 3
KR - Corea 3
PE - Perù 3
PH - Filippine 3
RO - Romania 3
UA - Ucraina 3
GT - Guatemala 2
HN - Honduras 2
HR - Croazia 2
LK - Sri Lanka 2
MA - Marocco 2
PS - Palestinian Territory 2
UY - Uruguay 2
VN - Vietnam 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AR - Argentina 1
AT - Austria 1
CH - Svizzera 1
CL - Cile 1
KE - Kenya 1
NZ - Nuova Zelanda 1
OM - Oman 1
PL - Polonia 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
TL - Timor Orientale 1
TT - Trinidad e Tobago 1
VE - Venezuela 1
Totale 1.969
Salva come PNG Salva come JPEG
Città #
Singapore 162
Chandler 124
Munich 62
Ashburn 50
Chicago 48
Santa Clara 48
London 39
Milan 26
Lawrence 24
Princeton 24
Turku 24
Catanzaro 22
Hong Kong 18
Naples 18
Amman 13
Boardman 12
Carbonia 12
Helsinki 11
Los Angeles 10
Ottawa 10
Parma 10
San Nicola Manfredi 10
Spezzano della Sila 10
The Dalles 10
Wilmington 10
New York 9
Rome 9
Delhi 8
Irbid 8
Brooklyn 7
Kaunas 7
Madrid 7
San Francisco 7
Santo Stefano di Rogliano 7
São Paulo 7
Cosenza 6
Ercolano 6
Seattle 6
Stockholm 6
Afragola 5
Atlanta 5
Cardiff 5
Chennai 5
Des Moines 5
Frankfurt am Main 5
Lucknow 5
Olomouc 5
Redmond 5
Riyadh 5
Sacramento 5
Addis Ababa 4
Brescia 4
Hyderabad 4
Jeddah 4
Kuala Lumpur 4
Lahore 4
Montreal 4
Nicosia 4
Pune 4
Redwood City 4
Richmond 4
West Jordan 4
Acquaviva delle Fonti 3
Ajman 3
Banyumas 3
Berlin 3
Bologna 3
Bristol 3
Castrovillari 3
Catania 3
Charlotte 3
Chía 3
Dallas 3
Dubai 3
Faisalabad 3
Grottaglie 3
Islamabad 3
Johannesburg 3
Lima 3
Melito di Porto Salvo 3
Mileto 3
Noida 3
Norwalk 3
Nuremberg 3
Oxford 3
Palermo 3
Paola 3
Quţūr 3
San Antonio 3
Santo Tirso 3
Seoul 3
Shanghai 3
Sofia 3
Tokyo 3
Washington 3
Waterford 3
Agrigento 2
Amsterdam 2
Ankara 2
Assago 2
Totale 1.120
Salva come PNG Salva come JPEG
Nome #
Pharmacogenetics/Pharmacogenomics of Drug-Metabolizing Enzymes and Transporters 372
A Novel Bispecific T-Cell Engager (CD1a x CD3ε) BTCE Is Effective against Cortical-Derived T Cell Acute Lymphoblastic Leukemia (T-ALL) Cells 87
miR-22 suppresses DNA ligase III addiction in multiple myeloma 85
Safety and activity of the first-in-class locked nucleic acid (LNA) miR-221 selective inhibitor in refractory advanced cancer patients: a first-in-human, phase 1, open-label, dose-escalation study 83
miR-221/222 as biomarkers and targets for therapeutic intervention on cancer and other diseases: A systematic review 70
Therapeutic afucosylated monoclonal antibody and bispecific T-cell engagers for T-cell acute lymphoblastic leukemia 56
DMET-Analyzer: automatic analysis of Affymetrix DMET Data 54
Identifying prognostic markers for multiple myeloma through integration and analysis of MMRF-CoMMpass data 50
A peroxisome proliferator-activated receptor gamma (PPARG) polymorphism is associated with zoledronic acid-related osteonecrosis of the jaw in multiple myeloma patients: analysis by DMET microarray profiling 48
The First-In-Class Anti-AXL×CD3ε Pronectin™-Based Bispecific T-Cell Engager Is Active in Preclinical Models of Human Soft Tissue and Bone Sarcomas 47
Error-prone DNA repair pathways as determinants of immunotherapy activity: an emerging scenario for cancer treatment 47
miR-21 antagonism abrogates Th17 tumor promoting functions in multiple myeloma 47
Trabectedin triggers direct and NK-mediated cytotoxicity in multiple myeloma. 45
A Prognostic and Carboplatin Response Predictive Model in Ovarian Cancer: A Mono-Institutional Retrospective Study Based on Clinics and Pharmacogenomics 44
Inhibition of EZH2 triggers the tumor suppressive miR-29b network in multiple myeloma 43
Exploiting MYC-induced PARPness to target genomic instability in multiple myeloma 43
From single level analysis to multi-omics integrative approaches: A powerful strategy towards the precision oncology 42
DmetTM genotyping: Tools for biomarkers discovery in the era of precision medicine 41
Allometric scaling approaches for predicting human pharmacokinetic of a locked nucleic acid oligonucleotide targeting cancer-associated miR-221 40
Mir-22 modulates lenalidomide activity by counteracting myc addiction in multiple myeloma 40
Exploiting DNA Ligase III addiction of multiple myeloma by flavonoid Rhamnetin 38
TERRA G-quadruplex stabilization as a new therapeutic strategy for multiple myeloma 37
Mmrf-commpass data integration and analysis for identifying prognostic markers 37
Pharmacogenomic Profiling of ADME Gene Variants: Current Challenges and Validation Perspectives 36
Integration of DNA Microarray with Clinical and Genomic Data 36
Dose-Finding Study and Pharmacokinetics Profile of the Novel 13-Mer Antisense miR-221 Inhibitor in Sprague-Dawley Rats 35
Pharmacogenomics biomarker discovery and validation for translation in clinical practice. 34
The New Microtubule-Targeting Agent SIX2G Induces Immunogenic Cell Death in Multiple Myeloma 33
Genetic variants associated with gastrointestinal symptoms in Fabry disease. 33
null 31
Mirnas and lncrnas as novel therapeutic targets to improve cancer immunotherapy 30
Ethical Perspectives on Pharmacogenomic Profiling 29
Risk Alleles for Multiple Myeloma Susceptibility in ADME Genes 29
Safety and activity of the first-in-class locked nucleic acid (LNA) miR-221 selective inhibitor in refractory advanced cancer patients: a first-in-human, phase 1, open-label, dose-escalation study 28
From Single Level Analysis to Multi-Omics Integrative Approaches: A Powerful Strategy towards the Precision Oncology 27
Genetic variants associated with Fabry disease progression despite enzyme replacement therapy 27
Autophagy and neuroprotection in astrocytes exposed to 6-hydroxydopamine is negatively regulated by NQO2: relevance to Parkinson’s disease 25
Pembrolizumab plus lenvatinib in advanced endometrial cancer: case report and systematic review of lung toxicity 24
Development and validation of bioanalytical methods for LNA-i-miR-221 quantification in human plasma and urine by LC-MS/MS 24
Genetic Biomarkers of Sorafenib Response in Patients with Hepatocellular Carcinoma 21
Identification of ADME genes polymorphic variants linked to trastuzumab-induced cardiotoxicity in breast cancer patients: Case series of mono-institutional experience 20
Modeling UGT2B7 and NR1I3 genes through multilayer network to highlight hidden link with taxane neurotoxicity 17
Polymorphisms and Pharmacogenomics of NQO2: The Past and the Future 11
Bioinformatic challenges for pharmacogenomic study: tools for genomic data analysis 10
Reprogrammed lipid metabolism in advanced resistant cancers: an upcoming therapeutic opportunity 10
The impact of PARP inhibitors in the whole scenario of ovarian cancer management: A systematic review and network meta-analysis 9
null 2
Totale 2.077
Salva come PNG Salva come JPEG
Categoria #
all - tutte 17.686
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.686
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202157 0 1 4 7 6 6 6 7 8 11 1 0
2021/2022128 2 0 0 22 5 2 10 22 30 17 13 5
2022/2023376 54 28 29 10 42 30 5 28 40 42 47 21
2023/2024469 87 34 42 37 41 70 27 38 10 17 32 34
2024/2025843 74 20 28 42 51 109 51 53 51 22 149 193
2025/2026166 102 64 0 0 0 0 0 0 0 0 0 0
Totale 2.077